• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者的冠状动脉钙化:一项系统评价

Coronary Artery Calcification in Rheumatoid Arthritis Patients: A Systematic Review.

作者信息

Nagy Stephanie, Ditchek Jordan, Kesselman Marc M

机构信息

Rheumatology, Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Davie, USA.

Radiology, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, USA.

出版信息

Cureus. 2024 Sep 30;16(9):e70517. doi: 10.7759/cureus.70517. eCollection 2024 Sep.

DOI:10.7759/cureus.70517
PMID:39479072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524640/
Abstract

Rheumatoid arthritis (RA) is one of the leading autoimmune causes of inflammatory arthropathy worldwide. The musculoskeletal impacts of RA are well described within the literature. More recently, research efforts have highlighted that inflammation associated with the condition is not solely isolated to the joint synovium. Specifically, data has demonstrated that the cardiovascular system is negatively impacted by inflammation tied to RA, with adverse cardiovascular outcomes considered the leading cause of mortality among patients with RA. One approach to determine the risk for cardiovascular disease (CVD) is computed tomography (CT) coronary angiography, a noninvasive imaging approach that analyzes the calcifications within the coronary vessels. This has increasingly been utilized to analyze plaque burden and vessel obstruction, which is measured using the coronary artery calcium (CAC) score. A total of 305 articles were analyzed, and 11 articles were selected for this review based on inclusion and exclusion criteria. The results indicated that nearly 60% of patients with RA experienced an elevated CAC score. As such, patients with RA likely carry a higher risk for adverse cardiovascular outcomes as compared to their healthy counterparts. Additional research is warranted based on these findings to determine whether the addition of CT coronary angiography and analysis of laboratory markers for CVD, including lipid markers in standard protocols for RA comorbid assessment, would help to reduce adverse cardiovascular complications.

摘要

类风湿性关节炎(RA)是全球范围内导致炎症性关节病的主要自身免疫病因之一。RA对肌肉骨骼的影响在文献中有充分描述。最近,研究工作强调与该病症相关的炎症并非仅局限于关节滑膜。具体而言,数据表明心血管系统会受到与RA相关炎症的负面影响,不良心血管结局被认为是RA患者死亡的主要原因。确定心血管疾病(CVD)风险的一种方法是计算机断层扫描(CT)冠状动脉造影,这是一种分析冠状动脉内钙化的非侵入性成像方法。这种方法越来越多地用于分析斑块负荷和血管阻塞情况,血管阻塞情况通过冠状动脉钙化(CAC)评分来衡量。共分析了305篇文章,并根据纳入和排除标准选择了11篇文章进行本综述。结果表明,近60%的RA患者CAC评分升高。因此,与健康人相比,RA患者可能发生不良心血管结局的风险更高。基于这些发现,有必要进行更多研究,以确定在RA合并症评估的标准方案中增加CT冠状动脉造影和分析CVD实验室标志物(包括脂质标志物)是否有助于减少不良心血管并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/57d74e068b4c/cureus-0016-00000070517-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/926298a7112c/cureus-0016-00000070517-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/29f4ef3aec7a/cureus-0016-00000070517-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/26fcbb384f70/cureus-0016-00000070517-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/57d74e068b4c/cureus-0016-00000070517-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/926298a7112c/cureus-0016-00000070517-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/29f4ef3aec7a/cureus-0016-00000070517-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/26fcbb384f70/cureus-0016-00000070517-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b56/11524640/57d74e068b4c/cureus-0016-00000070517-i04.jpg

相似文献

1
Coronary Artery Calcification in Rheumatoid Arthritis Patients: A Systematic Review.类风湿关节炎患者的冠状动脉钙化:一项系统评价
Cureus. 2024 Sep 30;16(9):e70517. doi: 10.7759/cureus.70517. eCollection 2024 Sep.
2
Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.类风湿关节炎早期抗风湿治疗前冠状动脉钙化。
Rheumatol Int. 2018 Feb;38(2):211-217. doi: 10.1007/s00296-017-3860-9. Epub 2017 Oct 27.
3
Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.类风湿关节炎患者 18 个月冠状动脉钙化的动态变化。
Rheumatol Int. 2018 Jul;38(7):1217-1224. doi: 10.1007/s00296-018-4045-x. Epub 2018 May 11.
4
Cardiovascular disease risk calculators to reflect the subclinical atherosclerosis of coronary artery in rheumatoid arthritis: a pilot study.反映类风湿关节炎患者冠状动脉亚临床动脉粥样硬化的心血管疾病风险计算器:一项初步研究。
BMC Rheumatol. 2021 Aug 30;5(1):39. doi: 10.1186/s41927-021-00213-3.
5
Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments.类风湿关节炎中的冠状动脉和腹主动脉钙化:与传统心血管危险因素、疾病特征及伴随治疗的关系
J Rheumatol. 2014 Nov;41(11):2137-44. doi: 10.3899/jrheum.140239. Epub 2014 Oct 1.
6
Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study.肾衰竭患者的冠状动脉钙化和主动脉瓣钙化:一项性别细分研究。
Biol Sex Differ. 2023 Jul 13;14(1):48. doi: 10.1186/s13293-023-00530-x.
7
Integrating cardiovascular risk assessment into mobile low-dose CT lung screenings in rural Appalachia: A comprehensive analysis of the relationship between lung cancer risk, coronary artery calcium burden, and cardiovascular risk reduction strategies.将心血管风险评估纳入阿巴拉契亚农村地区的移动低剂量CT肺癌筛查:对肺癌风险、冠状动脉钙化负荷和心血管风险降低策略之间关系的综合分析。
Am J Prev Cardiol. 2024 Aug 11;19:100719. doi: 10.1016/j.ajpc.2024.100719. eCollection 2024 Sep.
8
Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis.口服补钙与类风湿关节炎患者冠状动脉钙化之间无关联。
Arthritis Rheumatol. 2015 Jun;67(6):1465-1473. doi: 10.1002/art.39100.
9
Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease.基于冠状动脉钙化数据及报告系统(CAC-DRS)的冠状动脉钙化评分系统可预测无心血管疾病史的潜在可治愈肺癌患者发生主要不良心血管事件或全因死亡的风险。
Heart Vessels. 2020 Nov;35(11):1483-1493. doi: 10.1007/s00380-020-01624-x. Epub 2020 May 22.
10
The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.2013 年美国心脏病学会/美国心脏协会心血管风险评分识别出具有高冠状动脉钙化评分的类风湿关节炎患者的能力。
Arthritis Rheumatol. 2015 Feb;67(2):381-5. doi: 10.1002/art.38944.

引用本文的文献

1
Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management.慢性炎症性疾病与心血管风险:当前见解及优化管理的未来策略
Int J Mol Sci. 2025 Mar 27;26(7):3071. doi: 10.3390/ijms26073071.

本文引用的文献

1
Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: A comparative multicentre observational study.类风湿关节炎患者血清阳性和血清阴性自身抗体状态的临床意义:一项多中心比较观察性研究。
Rheumatol Immunol Res. 2024 Mar 31;5(1):57-65. doi: 10.1515/rir-2024-0007. eCollection 2024 Mar.
2
The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review.阿司匹林、他汀类药物、秋水仙碱和白介素-1 抑制剂在预防心血管事件中的作用:系统综合评价。
J Osteopath Med. 2023 Oct 25;124(3):97-106. doi: 10.1515/jom-2023-0082. eCollection 2024 Mar 1.
3
Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.
1990年至2020年全球、区域和国家类风湿性关节炎负担及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610. doi: 10.1016/S2665-9913(23)00211-4. eCollection 2023 Oct.
4
Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?钙评分对低或中度心血管风险的类风湿关节炎患者有用吗?
J Clin Med. 2022 Aug 18;11(16):4841. doi: 10.3390/jcm11164841.
5
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance.PCSK9 抑制剂在心血管风险管理中的应用:实用指南。
Vasc Health Risk Manag. 2022 Jul 20;18:555-566. doi: 10.2147/VHRM.S275739. eCollection 2022.
6
Immunomodulatory role of T helper cells in rheumatoid arthritis : a comprehensive research review.类风湿关节炎中辅助性T细胞的免疫调节作用:一项综合研究综述
Bone Joint Res. 2022 Jul;11(7):426-438. doi: 10.1302/2046-3758.117.BJR-2021-0594.R1.
7
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.EULAR 建议:风湿和肌肉骨骼疾病(包括红斑狼疮和抗磷脂综合征)的心血管风险管理。
Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2.
8
Low attenuation plaque volume on coronary computed tomography angiography is associated with plaque progression.冠状动脉 CT 血管造影显示低衰减斑块体积与斑块进展有关。
Coron Artery Dis. 2022 May 1;33(3):176-181. doi: 10.1097/MCA.0000000000001103.
9
Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs.类风湿关节炎的免疫致病机制及抗炎药物的应用
Intractable Rare Dis Res. 2021 Aug;10(3):154-164. doi: 10.5582/irdr.2021.01022.
10
Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress.雌激素通过氧化应激对心血管疾病的保护作用。
Oxid Med Cell Longev. 2021 Jun 28;2021:5523516. doi: 10.1155/2021/5523516. eCollection 2021.